Acutaas Chemicals Ltd (formerly Ami Organics Limited) is one of India’s foremost research and development-driven manufacturers of specialty chemicals. The company produces advanced pharmaceutical intermediates, active pharmaceutical ingredients (APIs), and materials for agrochemicals, semiconductors, and fine chemicals.
Q2 FY26 Earnings Summary
Consolidated revenue stood at ₹306 crore, up 23.89% year on year from ₹247 crore.
Total expenses rose 7.32% year on year to ₹220 crore from ₹205 crore.
Consolidated Net Profit surged 89.47% to ₹72 crore from ₹38 crore in the same quarter last year.
Earnings Per Share (EPS) increased 93.42% to ₹8.82 from ₹4.56 in Q2 FY25.
EBITDA grew nearly 95% year on year to ₹95 crore, with margins improving to 31.1% from 19.8%.
Operational and Business Highlights
The company recorded strong performance driven by its advanced pharmaceutical intermediates segment and stable contributions from specialty chemicals.
Exports accounted for nearly 76% of revenues, reflecting robust demand across key international markets.
Investments in capacity expansion and entry into new high-margin segments such as battery chemicals and semiconductors are expected to further strengthen growth.
The company also reported efficiency gains through process optimization and enhanced product mix.
Financial Position and Outlook
Acutaas Chemicals continues to maintain a resilient balance sheet with healthy cash flows and strong liquidity.
The management remains confident of achieving around 25% revenue growth for FY26, supported by expanding global partnerships and diversification into value-added chemical verticals.
Focused R&D initiatives, technological leadership, and a growing international footprint position Acutaas Chemicals to sustain long-term growth in the specialty and advanced materials sector.
Acutaas Chemicals Ltd’s continued growth underscores its emergence as a key player in India’s high-value specialty chemicals industry heading into FY26 and beyond.
Explore the company’s past earnings and latest concall transcripts, click here to visit the AlphaStreet India News Channel.